Search

Ocugen Inc

Închisă

1.34 -3.6

Rezumat

Modificarea prețului

24h

Curent

Minim

1.34

Maxim

1.43

Indicatori cheie

By Trading Economics

Venit

-5.7M

-25M

Vânzări

-45K

1.5M

EPS

-0.07

Marjă de profit

-1,671.841

Angajați

116

EBITDA

-3.1M

-20M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+632.14% upside

Dividende

By Acuity

Următoarele câștiguri

4 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

28M

444M

Deschiderea anterioară

4.94

Închiderea anterioară

1.34

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 aug. 2026, 23:56 UTC

News

Molson Coors Beverage Co shares advanced in after-market hours to $43.20, following Q2 revenues of $3.10 billion that met analyst expectations.

13 aug. 2026, 23:56 UTC

GitLab Inc. shares are trading lower in after-market hours, despite an earlier rebound from session lows. No specific news was identified.

13 aug. 2026, 23:56 UTC

Pegasystems Inc. shares are lower in after-market trading, with no specific news identified. The broader market reacts to rising initial jobless claims.

13 aug. 2026, 23:56 UTC

Zebra Technologies shares are trading higher in after-market hours, maintaining strength above its 20-day moving average and near the upper end of its one-month range.

13 aug. 2026, 23:56 UTC

Correlated Moves

T Rowe Price Group Inc shares are lower in after-market trading, extending a trend of declines over the past three sessions amid broader market weakness.

13 aug. 2026, 23:56 UTC

iShares TIPS Bond ETF traded roughly flat during after-market hours. The asset remains near the lower end of its one-month trading range.

13 aug. 2026, 23:56 UTC

Cherry Hill Mortgage Investment Corp is trading lower in after-market hours, declining from earlier gains despite remaining above its 20-day moving average.

13 aug. 2026, 23:56 UTC

Toast Inc shares are lower in after-market trading. No specific company news was identified to explain this price movement.

13 aug. 2026, 23:56 UTC

Correlated Moves

Skyworks Solutions Inc shares declined in after-market trading, influenced by broader market movements and rising initial jobless claims indicating potential labor market softness.

13 aug. 2026, 23:56 UTC

Shares of Camtek Ltd are trading higher in after-market hours, remaining above their 20-day moving average despite routine performance during the regular session.

13 aug. 2026, 23:56 UTC

NetApp Inc. shares are higher in after-market trading, remaining above their 20-day moving average amid broader market dynamics and rising initial jobless claims.

13 aug. 2026, 23:56 UTC

Correlated Moves

TPG Inc shares declined in after-market trading, settling lower after earlier gains. The drop aligns with a slight decrease in the Russell 2000 Index.

13 aug. 2026, 23:56 UTC

News
Event

Bristol-Myers Squibb's shares are lower after FDA approval of ZENBEXUS for multiple myeloma, amid concerns over drug risks and ongoing trial verification.

13 aug. 2026, 23:56 UTC

Correlated Moves
Macro News
ETF Constituents

iShares MSCI South Korea ETF gains in after-market trading, reflecting KOSPI's surge amid positive sentiment around interest rates and U.S. stock performance.

13 aug. 2026, 23:52 UTC

Kura Oncology Inc is trading higher in after-market hours, reflecting broader market optimism following recent economic data and a stable producer price index.

13 aug. 2026, 23:51 UTC

Tyler Technologies Inc shares are higher in after-market trading, reflecting strong performance since Thursday's close, despite no specific news identified to explain the movement.

13 aug. 2026, 23:51 UTC

Clean Energy Fuels Corp shares are lower in after-market hours, reversing earlier gains amid broader market sentiment influenced by recent economic data.

13 aug. 2026, 23:51 UTC

Gladstone Land Corp. shares rose in after-market trading, recovering from earlier losses amid broader market optimism following unchanged producer price index data.

13 aug. 2026, 23:51 UTC

L3Harris Technologies Inc. shares are higher in after-hours trading, reflecting positive market sentiment amid decreased expectations for a Federal Reserve interest rate hike.

13 aug. 2026, 23:51 UTC

StoneX Group Inc shares are lower in after-market hours, with no specific news identified. The asset remains near the lower end of its one-month trading range.

13 aug. 2026, 23:51 UTC

Asia equity markets show mixed performance as Japan's Nikkei rises on tech optimism and potential rate hikes, while China's Shanghai Composite dips amid geopolitical tensions and falling oil prices; U.S. jobless claims exceed expectations, softening inflation outlook.

13 aug. 2026, 23:51 UTC

Global equity markets rise, led by U.S. mega-caps, while mixed economic signals emerge from jobless claims and inflation data.

13 aug. 2026, 23:51 UTC

Mixed trading in European equities as UK GDP growth exceeds expectations while industrial production shows weakness amidst fluctuating oil prices and trade balance concerns.

13 aug. 2026, 23:51 UTC

U.S. equity indices remain flat as investors weigh mixed economic signals, rising jobless claims, and easing inflation amid geopolitical tensions and falling oil prices.

13 aug. 2026, 23:51 UTC

Australia's Westpac Consumer Confidence Report Set for August 18 Amidst Cautious Market Sentiment and Inflation Concerns.

13 aug. 2026, 23:51 UTC

Michigan Consumer Sentiment Report Set for August 14, Forecasted at 54.5 Amid Cautious Optimism Following Stable Inflation Data

13 aug. 2026, 23:51 UTC

US Business Inventories MoM data for June 2026 set to release on August 14, with a modest increase of 0.1% anticipated amid cautious market sentiment and inflation concerns.

13 aug. 2026, 23:51 UTC

Cautious Market Awaits July 2026 Building Permits Data Amid Ongoing Construction Sector Weakness and Rising Costs

13 aug. 2026, 23:51 UTC

NIO Inc shares are higher in after-market trading, reflecting broader market trends amid unchanged producer prices and reduced interest rate hike expectations.

13 aug. 2026, 23:51 UTC

Digital Realty Trust Inc shares are higher in after-market trading, reflecting broader market optimism following recent economic data and a recovery from earlier lows.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

632.14% sus

Prognoză pe 12 luni

Medie 10.25 USD  632.14%

Maxim 12 USD

Minim 8 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

4

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat